[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @spontonic Spontonic Spontonic posts on X about $bmy, bmy, $4507t, $smmt the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::38920802/interactions)  - X Week XXX +38% - X Month XXXXX -XX% - X Months XXXXXX +143% - X Year XXXXXX +126% ### Mentions: X [#](/creator/twitter::38920802/posts_active)  - X Week X -XX% - X Month XX -XX% - X Months XXX +122% - X Year XXX +103% ### Followers: XXX [#](/creator/twitter::38920802/followers)  - X Week XXX +0.29% - X Month XXX +0.43% - X Months XXX +5.60% - X Year XXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::38920802/influencer_rank)  ### Social Influence [#](/creator/twitter::38920802/influence) --- **Social category influence** [stocks](/list/stocks) [travel destinations](/list/travel-destinations) **Social topic influence** [$bmy](/topic/$bmy), [bmy](/topic/bmy), [$4507t](/topic/$4507t), [$smmt](/topic/$smmt), [shanghai](/topic/shanghai), [$til](/topic/$til), [$bntx](/topic/$bntx), [fda](/topic/fda), [has been](/topic/has-been), [sanofi](/topic/sanofi) **Top assets mentioned** [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Sanofi (SNY)](/topic/sanofi) ### Top Social Posts [#](/creator/twitter::38920802/posts) --- Top posts by engagements in the last XX hours ""The anti-PD-1 moiety of JS207 adopts a Fab structure to maintain binding affinity to PD-1 and thereby attain better enrichment in the tumor microenvironment". at a cost of a little more tox than other anti-PD-1 Fabs" [X Link](https://x.com/spontonic/status/1979229400139993103) [@spontonic](/creator/x/spontonic) 2025-10-17T16:53Z XXX followers, XXX engagements "@qniatof $BMY #CCR8 And relevant the "hell freezes over" trial completion date has been extended by X full years to 2028" [X Link](https://x.com/spontonic/status/1970642660340965868) [@spontonic](/creator/x/spontonic) 2025-09-24T00:13Z XXX followers, XXX engagements "@qniatof 2/ could get a little weird. M.D. Anderson launching a phase II as $BMY extends its phase I by another X years is just more of the same. But I'm leaning toward LaNova Shionogi AND BMY being "go". Would be great to have a comparative handle on epitope definition" [X Link](https://x.com/spontonic/status/1970961202504401021) [@spontonic](/creator/x/spontonic) 2025-09-24T21:19Z XXX followers, XXX engagements "#CCR8 Shimon Sakaguchi and the Nobel Prize in Physiology or Medicine 2025. among other accomplishments" [X Link](https://x.com/spontonic/status/1975304706726715424) [@spontonic](/creator/x/spontonic) 2025-10-06T20:58Z XXX followers, XXX engagements "Anti-#CCR8 MAb S-531011 Shionogi" [X Link](https://x.com/spontonic/status/1975669459089326415) [@spontonic](/creator/x/spontonic) 2025-10-07T21:07Z XXX followers, XXX engagements "Sort of figured. But of course AI agents do make mistakes and can't predict a future shaped by existing but unforeseen biology. Junshi attempting to use tori's own Fab to cut into its partner's sales" [X Link](https://x.com/spontonic/status/1979251392520032376) [@spontonic](/creator/x/spontonic) 2025-10-17T18:21Z XXX followers, XX engagements "Amgen v. Sanofi: The 2023 Supreme Court ruling in Amgen v. Sanofi affirmed the need for patents to sufficiently enable the full scope of a claimed invention reinforcing the idea that broad speculative claims are not valid. By analogy a license" [X Link](https://x.com/spontonic/status/1979252764279792010) [@spontonic](/creator/x/spontonic) 2025-10-17T18:26Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Spontonic posts on X about $bmy, bmy, $4507t, $smmt the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks travel destinations
Social topic influence $bmy, bmy, $4507t, $smmt, shanghai, $til, $bntx, fda, has been, sanofi
Top assets mentioned Bristol-Myers Squibb Co (BMY) Summit Therapeutics Inc. Common Stock (SMMT) Sanofi (SNY)
Top posts by engagements in the last XX hours
""The anti-PD-1 moiety of JS207 adopts a Fab structure to maintain binding affinity to PD-1 and thereby attain better enrichment in the tumor microenvironment". at a cost of a little more tox than other anti-PD-1 Fabs"
X Link @spontonic 2025-10-17T16:53Z XXX followers, XXX engagements
"@qniatof $BMY #CCR8 And relevant the "hell freezes over" trial completion date has been extended by X full years to 2028"
X Link @spontonic 2025-09-24T00:13Z XXX followers, XXX engagements
"@qniatof 2/ could get a little weird. M.D. Anderson launching a phase II as $BMY extends its phase I by another X years is just more of the same. But I'm leaning toward LaNova Shionogi AND BMY being "go". Would be great to have a comparative handle on epitope definition"
X Link @spontonic 2025-09-24T21:19Z XXX followers, XXX engagements
"#CCR8 Shimon Sakaguchi and the Nobel Prize in Physiology or Medicine 2025. among other accomplishments"
X Link @spontonic 2025-10-06T20:58Z XXX followers, XXX engagements
"Anti-#CCR8 MAb S-531011 Shionogi"
X Link @spontonic 2025-10-07T21:07Z XXX followers, XXX engagements
"Sort of figured. But of course AI agents do make mistakes and can't predict a future shaped by existing but unforeseen biology. Junshi attempting to use tori's own Fab to cut into its partner's sales"
X Link @spontonic 2025-10-17T18:21Z XXX followers, XX engagements
"Amgen v. Sanofi: The 2023 Supreme Court ruling in Amgen v. Sanofi affirmed the need for patents to sufficiently enable the full scope of a claimed invention reinforcing the idea that broad speculative claims are not valid. By analogy a license"
X Link @spontonic 2025-10-17T18:26Z XXX followers, XX engagements
/creator/x::spontonic